C9 and amyotrophic lateral sclerosis: These findings suggest that telmisartan has a neuroprotective effect in C9-ALS models derived from patient induced pluripotent stem cells (iPSCs) by enhancing MN survival in a non-cell-autonomous manner and reducing C9-microglia-mediated pro-inflammatory cytokine levels.